CN Stock MarketDetailed Quotes

002550 Changzhou Qianhong Biopharma

Watchlist

6.01
-0.06-0.99%

Market Closed Jan 3 15:00 CST

7.69BMarket Cap26.24P/E (TTM)

Changzhou Qianhong Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Changzhou Qianhong Biopharma Q3 2024 Earnings Date

Currency：CNYOct 18, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	352.01M	--
		-13.97%
EPS	--	0.10	--
		--

Analyst Rating

Strong Buy

Jan 3, 2025

Changzhou Qianhong Biopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 2.175B	--
--	2024/FY	-- / 1.831B	--
--	2023/FY	1.814B / 2.057B	--
--	2019/FY	1.675B / 1.568B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 2.175B--

--2024/FY-- / 1.831B--

--2023/FY1.814B / 2.057B--

--2019/FY1.675B / 1.568B--

--------

Unlock Free Earnings Estimates

Open Account

Changzhou Qianhong Biopharma Earnings Reports

Qianhong Pharmaceutical: Report for the third quarter of 2024

Oct 17, 2024 12:00 ET

Qianhong Pharmaceutical: 2024-035 Qianhong Pharmaceutical: Performance forecast for the first three quarters of 2024

Oct 8, 2024 12:00 ET

Changzhou Qianhong Biopharma: Summary of Half-Year Report in 2024.

Aug 15, 2024 12:00 ET

Changzhou Qianhong Biopharma: Half-year report for the year 2024.

Aug 15, 2024 12:00 ET

Top CN Stock Gainers

Symbol Price % Chg

Baotou Tianhe Magnetics Technology

Geovis Insighter Technology

Xdc Industries(Shenzhen)Limited

300615

16.55 +20.01%

See the daily top gainer.

Analysis

Analyst Rating

Updated: Jan 3, 2025

Strong Buy

Strong Buy
66.67%
Buy
33.33%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data